email    contact
マットラブのソフトウエア
を利用した
高度な解析能力を
有した製品です。

多チャンネルを
同時、リアルタイムで
表示します。

心電図は、8チャンエルの
波形サンプリングデジタル信号
及びRR間隔信号
を同時、リアルタイムで
三次元、周波数解析、
各種自律神経等の
解析法で表示します。

12誘導心電図や、

3チャンエル心電図、呼吸、脳波、筋電等

などのワイヤレス監視・データ連続採集を

ご提案します。

今や、無線の時代到来です。

動作中、イクサザイ中、行動中、
体育中、運動中、エアロビクス中、
ジョギング中、登山中、作業中、
仕事中、ストレステスト中、
などの最中のデータ取得が
可能となりました。

画像例は下記をご参照願います。

http://www.din.or.jp/~meditekn/medi_hp/
上記の一番下部に解説付きで、応用例を掲載
http://www.din.or.jp/~meditekn/medi_hp/duna/
ラブテック社製マスターステップの使用例掲載
http://www.din.or.jp/~meditekn/medi_hp/duna2/
医大検査室での使用例、画面例及び記録例も掲載
http://www.din.or.jp/~meditekn/medi_hp/remoterunning12ecgs/
ソニーの超小型パソコンを利用したランニング仕様の用途例
http://www.din.or.jp/~meditekn/medi_hp/aerobicacc/
米国循環器学会で推奨された心臓病患者への心臓リハビリ法としてのエアロビックの効能についての発表
http://www.din.or.jp/~meditekn/medi_hp/gtec/
出力のRR間隔データの解析例、これは別売のソフトウエアとなります。
http://www.din.or.jp/~meditekn/medi_hp/stressdata/
負荷試験での重要な医学的指標、米国心臓病学会のスタンダードとして発布
http://www.din.or.jp/~meditekn/medi_hp/labtechholter/ ラブテックパソコンホルタのご紹介
http://www.din.or.jp/~meditekn/medi_hp/labtech1/
ラブテック社製品としてのパソコン式の利用価値 等を掲載しております
先天性心疾患ソフトウエア
Pedcath8
画像例は下記をご参照願います。

http://www.din.or.jp/~meditekn/medi_hp/
上記の一番下部に解説付きで、応用例を掲載
http://www.din.or.jp/~meditekn/medi_hp/duna/
ラブテック社製マスターステップの使用例掲載
http://www.din.or.jp/~meditekn/medi_hp/duna2/
医大検査室での使用例、画面例及び記録例も掲載
http://www.din.or.jp/~meditekn/medi_hp/remoterunning12ecgs/
ソニーの超小型パソコンを利用したランニング仕様の用途例
http://www.din.or.jp/~meditekn/medi_hp/aerobicacc/
米国循環器学会で推奨された心臓病患者への心臓リハビリ法としてのエアロビックの効能についての発表
http://www.din.or.jp/~meditekn/medi_hp/gtec/
出力のRR間隔データの解析例、これは別売のソフトウエアとなります。
http://www.din.or.jp/~meditekn/medi_hp/stressdata/
負荷試験での重要な医学的指標、米国心臓病学会のスタンダードとして発布
http://www.din.or.jp/~meditekn/medi_hp/labtechholter/ ラブテックパソコンホルタのご紹介
http://www.din.or.jp/~meditekn/medi_hp/labtech1/
ラブテック社製品としてのパソコン式の利用価値 等を掲載しております
最新Pedcath8 PedCath PedCath 導入理由書 PedCath 佐野シャント PedCath 川崎病 PedCath Network PedCath HIPAA PedCath
Examples of Images
先天性心疾患資料 Pedcath Examples of Images Pedcathの品目 PedCath 品目一覧 PedCath アトラスの本のご案内
アルテリオグラフ25 モバイル12誘導心電計 ワイヤレス12誘導心電計 ワイヤレス血圧心電計 ラブテックホルター心電計
複合機能医療機 Caretaker(研究用) Pedcath8(研究用) ワイヤレス医療機器 パラマテックホルター
Shimmer Sensing(研究用 Cardioview(研究用) Telemedicine(研究用) パソコン式医療機器(研究用) 頭蓋酸素飽和度
自律神経(研究用) Cardionics(シムレ―タ等) 研究用電子聴診器 輸入代行 薬事申請書類代行
非観血血圧付き心電図ホルタの文献   負荷心電図検査の医学文献      エアロビックの効果   心電・血圧ホルタ記録器
ブルーツース     デュナ   デュナの実例     遠隔同時表示    ラブテック製品    Labtech products
下記は、弊社ラインアップ品です、

PCの機能が向上し、Descrete Wavelet 手法が、お求めやすい低価格で

実現し、心房のP波を自動検出できるようになりました、

心房細動の自動解析能をお試し賜われれば幸いです


臨床用 薬事認可済


Labtech社は、当社独自の方法による

P波自動検出と心房細動自動解析手法

T Wave Alternans 解析手法を開発し、当社ホルターに搭載。


VectraCardiology,Heart Rate Variability ,TWA オルタナンス
Turbulence、3D可変表示、Spectral Analysis等が装備

Theory of the P wave detection

The algorithm first finds the  the possible positive and negative wave peaks
based on zero transition searching, then validates them with comparing
to reference P waves.

The P wave detection needs high amplitude resolution. This value is better,
than 0.6 uV / bit in the Cardiospy system.  With this resolution and
the effective filter system which uses wavelet transformation,
the Cardiospy system is able to detect P waves less than 50 uV of amplitude.

 

Validation of the P wave detector

The validation is carried out on 10 pcs 12 channel and 10 pcs 3 channel ECG
reference records. The reference records include the P wave  annotation.  12
of the 20 records are taken from the MitBih database, 8 records are
taken from the Labtech database (30000 ? 30007). 

12 ch records

s0014lre, s0292lre, s0302lre, s0331lre, s0364lre, s0422_re, s0431_re,
s0437_re, s0549_re, s0550_re

3 ch records

mgh001, mgh007, 30000, 30001, 30002, 30003, 30004, 30005, 30006, 30007

 

Validation result:

Sensitivity:                       95.42%

Positive predictivity:         97.16%


ケアテイカー研究用

非観血相対血圧・連続・ポータブル・ウエアラブル・一拍毎解析出力付き

httpswww.ncbi.nlm.nih.govpmcarticlesPMC5361833

 

BMC Anesthesiol. 2017; 17: 48.

Published online 2017 Mar 21. doi: 10.1186/s12871-017-0337-z

PMCID: PMC5361833

PMID: 28327093

Continuous Non-invasive finger cuff CareTakerR comparable to invasive intra-arterial pressure in patients undergoing major intra-abdominal surgery

Irwin Gratz,1 Edward Deal,1 Francis Spitz,1 Martin Baruch,2 I. Elaine Allen,3 Julia E. Seaman,4 Erin Pukenas,1 and Smith Jean1

Author information Article notes Copyright and License information Disclaimer

This article has been cited by other articles in PMC.

 

Associated Data

Data Availability Statement

The datasets generated during and analysed for the current study are available from the corresponding author on reasonable request.

 

Abstract

Background

Despite increased interest in non-invasive arterial pressure monitoring, the majority of commercially available technologies have failed to satisfy the limits established for the validation of automatic arterial pressure monitoring by the Association for the Advancement of Medical Instrumentation (AAMI). According to the ANSI/AAMI/ISO 81060?2:2013 standards, the group-average accuracy and precision are defined as acceptable if bias is not greater than 5 mmHg and standard deviation is not greater than 8 mmHg. In this study, these standards are used to evaluate the CareTakerR (CT) device, a device measuring continuous non-invasive blood pressure via a pulse contour algorithm called Pulse Decomposition Analysis.

Methods

A convenience sample of 24 patients scheduled for major abdominal surgery were consented to participate in this IRB approved pilot study. Each patient was monitored with a radial arterial catheter and CT using a finger cuff applied to the contralateral thumb. Hemodynamic variables were measured and analyzed from both devices for the first thirty minutes of the surgical procedure including the induction of anesthesia. The mean arterial pressure (MAP), systolic and diastolic blood pressures continuously collected from the arterial catheter and CT were compared. Pearson correlation coefficients were calculated between arterial catheter and CT blood pressure measurements, a Bland-Altman analysis, and polar and 4Q plots were created.

Results

The correlation of systolic, diastolic, and mean arterial pressures were 0.92, 0.86, 0.91, respectively (p?<?0.0001 for all the comparisons). The Bland-Altman comparison yielded a bias (as measured by overall mean difference) of ?0.57, ?2.52, 1.01 mmHg for systolic, diastolic, and mean arterial pressures, respectively with a standard deviation of 7.34, 6.47, 5.33 mmHg for systolic, diastolic, and mean arterial pressures, respectively (p?<?0.001 for all comparisons). The polar plot indicates little bias between the two methods (90%/95% CI at 31.5°/52°, respectively, overall bias?=?1.5°) with only a small percentage of points outside these lines. The 4Q plot indicates good concordance and no bias between the methods.

Conclusions

In this study, blood pressure measured using the non-invasive CT device was shown to correlate well with the arterial catheter measurements. Larger studies are needed to confirm these results in more varied settings. Most patients exhibited very good agreement between methods. Results were well within the limits established for the validation of automatic arterial pressure monitoring by the AAMI.

Keywords: Non-Invasive, CareTaker, Central blood pressure, Finger cuff, Intra-Arterial pressure


Tensiomed 社 Arteriograph 24 血管脈波検査装置

ご注意:中心血圧と関連機能は検証が必要です、


臨床用ー薬事認可済

Central blood pressure: current evidence

and clinical importance

Carmel M. McEniery1*, John R. Cockcroft2, Mary J. Roman3,

Stanley S. Franklin4, and Ian B.Wilkinson1

1Clinical Pharmacology Unit, University of Cambridge, Addenbrookes Hospital, Box 110, Cambridge CB22QQ, UK; 2Department of Cardiology,Wales Heart Research Institute, Cardiff

CF14 4XN, UK; 3Division of Cardiology,Weill Cornell Medical College, New York, NY 10021, USA; and 4University of California, UCI School of Medicine, Irvine, CA 92697-4101, USA

Received 29 April 2013; revised 27 November 2013; accepted 17 December 2013; online publish-ahead-of-print 23 January 2014

and central pressure. Therefore, basing treatment decisions on central, rather than brachial pressure, is likely to have important implications

for the future diagnosis and management of hypertension. Such a paradigm shift will, however, require further, direct evidence that selectively

targeting central pressure, brings added benefit, over and above that already provided by brachial artery pressure.

Central pressure Blood pressure Anti-hypertensive treatment Cardiovascular risk

Introduction

The brachial cuff sphygmomanometer was introduced into medical

practice well over 100 years ago, enabling the routine, non-invasive,

measurement of arterial blood pressure. Life insurance companies

were among the first to capitalize on the information provided by

cuff sphygmomanometry, by observing that blood pressure in

largely asymptomatic individuals relates to future cardiovascular

risk?observations that are nowsupported by a wealth of epidemiological

data.1 The most recent Global Burden of Disease report2

identified hypertension as the leading cause of death and disability

worldwide. Moreover, data from over 50 years of randomized controlled

trials clearly demonstrate that lowering brachial pressure,

in hypertensive individuals, substantially reduces cardiovascular

events.1,3 For these reasons, measurement of brachial blood pressure

has become embedded in routine clinical assessment throughout the

developed world, and is one of the most widely accepted surrogate

measures for regulatory bodies.

The major driving force for the continued use of brachial blood

pressure has been its ease of measurement, and the wide variety of

devices available for clinical use. However, we have known for over

half a century that brachial pressure is a poor surrogate for aortic

pressure, which is invariably lower than corresponding brachial

values. Recent evidence suggests that central pressure is also more

strongly related to future cardiovascular events4 ? 7 than brachial

pressure, and responds differently to certain drugs.8,9 Appreciating

this provides an ideal framework for understanding the much publicized

inferiority of atenolol and some other beta-blockers,10 compared

with other drug classes, in the management of essential

hypertension. Although central pressure can now be assessed noninvasively

with the same ease as brachial pressure, clinicians are unlikely

to discard the brachial cuff sphygmomanometer without

robust evidence that cardiovascular risk stratification, and monitoring

response to therapy, are better when based on central rather

than peripheral pressure. Central pressure assessment and accuracy

will also have to be standardized, as it has been for brachial pressure

assessment with oscillometric devices. This review will discuss our

current understanding about central pressure and the evidence

required to bring blood pressure measurement, and cardiovascular

risk assessment into the modern era.

Physiological concepts

Arterial pressure varies continuously over the cardiac cycle, but in

clinical practice only systolic and diastolic pressures are routinely

reported. These are invariably measured in the brachial artery

using cuff sphygmomanometry?a practice that has changed little

over the last century. However, the shape of the pressure waveform

* Corresponding author. Tel: +44 1223 336806, Fax: +44 1223 216893, Email: cmm41@cam.ac.uk

Published on behalf of the European Society of Cardiology. All rights reserved. &The Author 2014. For permissions please email: journals.permissions@oup.com

European Heart Journal (2014) 35, 1719?1725 doi:10.1093/eurheartj/eht565

 

Pressure measured with a cuff and sphygmomanometer in the brachial artery is accepted as an important predictor of future cardiovascular risk.However, systolic pressure varies throughout the arterial tree, such that aortic (central) systolic pressure is actually lower than corresponding brachial values, although this difference is highly variable between individuals. Emerging evidence now suggests that central pressure is better related to future cardiovascular events than is brachial pressure. Moreover, anti-hypertensive drugs can exert differential effects on brachial and central pressure. Therefore, basing treatment decisions on central, rather than brachial pressure, is likely to have important implications for the future diagnosis and management of hypertension. Such a paradigm shift will, however, require further, direct evidence that selectively targeting central pressure, brings added benefit, over and above that already provided by brachial artery pressure.As discussed earlier, a full synthesis of the available evidence concerning

central pressure and the risk of future cardiovascular events is now required. However, it will also be necessary to determine the clinical relevance of differences between brachial and central pressure

for the individual patient, especially given the relatively high correlation between the two. Emerging data support the prognostic superiority of both 24-h ambulatory blood pressure monitoring

(ABPM)79 ? 81 andhomemonitoring81 in comparison with office measurements. Interestingly, a recent study82 demonstrated that 24-h ambulatory cuff pressures were comparable with office central pressure

measurements in the prediction of risk, although the significance of this study awaits confirmation.83 As yet, there are no data comparing the predictive value ofhomemonitoring vs. central pressure in the

prediction of risk. Ultimately, it will be necessary to evaluate the prognostic value of 24-h ambulatory central pressure.With the recent development of ambulatory central pressure systems,84,85 this is now

possible and it may be reasonable to hypothesize that 24-h central, rather than brachial ABPM would be superior in terms of risk prediction.

Cardioview は、パソコン心電計の
心電図の不整脈解析分類の正確性で、
下記検証データが学会で認められています、
低価格心電計として、ただ一つ正確さが認められている機種です。

ラブテックホルタ心電計 ラブテックホルタ心電計資料 ワイヤレスブルーツース100mの例 ケアテイカメディカル
中心血検証をお願いします アルテリオグラフの文献例 ケアテイカ MRI下非観血連続血圧計
先天性心疾患ソフト カルディオビューパンフレット カルディオビューとテレバイタル カルディオニクス製製品
メディカルテクニカ掲示板 メディカルテクニカ掲示板 リンク リンク
ラブテック社心臓リハビリ メタボリックテスト ラブテック社ワイヤレス12誘導心電計 ラブテック社12誘導心電計
ラブテック12誘導心電計 心電図解析 ラブテック社モバイル心電計 検診用心電計
ラブテックホルタ心電計 ラブテックホルタ心電計 ラブテックホルタ心電計 ラブテックホルタ心電計
ラブテックホルタ心電計 ラブテックネット心電図 シムレータ
ラブテック社心臓リハビリ
ラブテックホルタ心電計資料
心臓リハビリ12誘導心電計 タブレットの12誘導心電図での利用例
ワイヤレスブルーツース100mの例
米国遠隔医療機器 12誘導心電図電極 自動遠隔虚血補助器 遠隔睡眠解析
在宅糖尿病監視 遠隔無呼吸症監視 12誘導心電図電極 耳より生体信号
飛行機内などの遠隔心電図診断 在宅生体信号監視 国産心電図ケーブル 無呼吸監視
ディスポ型12誘導心電図電極 在宅医療 呼吸と心拍の遠隔監視 心音付き心電図
心電図等のケーブル類 遠隔医療多機能モニタ 多機能センサー 見守りレーダ
遠隔12誘導心電図試験 遠隔診断用椅子 簡易心電図電極式遠隔診断 WiMAX回線の遠隔診断
ベッドの漏れ検出
新型血圧測定 ケアテイカメディカル ケアテイカ 血圧制御
ケアテイカ ケアテイカ案内 ケアテイカのカフの位置 体内血圧測定
MRI下非観血連続血圧計